Related Experiment Videos
[Analysis for telomerase activity in various hematologic disorders]
Nihon Rinsho. Japanese Journal of Clinical Medicine
|June 5, 1998
Summary
Telomerase activity is prevalent in various hematologic malignancies, particularly blastic crisis of chronic myeloid leukemia (CML-BC) and myeloproliferative disease-blastic crisis (MPD-BC). Cyclin D/E expression did not correlate with telomerase activity in acute myeloid leukemia (AML) or lymphoma.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Context:
- Telomerase is a key enzyme in cellular immortalization and is implicated in various cancers.
- Understanding telomerase activity in hematologic disorders is crucial for diagnosis and prognosis.
- Previous studies have explored telomerase expression in different cancers, including breast cancer.
Purpose:
- To investigate and quantify telomerase activity across a spectrum of hematologic disorders, both malignant and non-malignant.
- To explore the relationship between telomerase activity and the expression of cyclins D/E in specific hematologic malignancies.
Summary:
- This study analyzed telomerase activity in 137 patients with various hematologic disorders.
- High telomerase activity was observed in myelodysplastic syndromes (MDS), overt leukemia, acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), CML-BC, MPD-BC, and aplastic anemia.
- Notably, CML-BC and MPD-BC exhibited very high telomerase activity.
- In AML and lymphoma cases, cyclin D/E expression was found to be unrelated to telomerase activity.
Impact:
- Provides a comprehensive overview of telomerase activity in diverse hematologic conditions.
- Suggests that telomerase activity may serve as a biomarker in certain hematologic malignancies.
- Highlights a lack of correlation between cyclin D/E and telomerase activity in AML/lymphoma, contrasting with findings in breast cancer.